Announce your event here
13th European Biological Inorganic Chemistry (EuroBIC 13)
2016-08-28 to 2016-09-01
Budapest, Hungry
In 1992 European bioinorganic chemists and biochemists decided to create the conference series EUROBIC (European Biological Inorganic Chemistry Conference) to bring together 300-400 participants for exchanging their latest results and different points of view in the field of metalloenzymes, metalloproteins, interactions of DNA with inorganic complexes, toxicology of metal ions, medicinal use of metal complexes, etc. EUROBIC and ICBIC (International Conference on Biological Inorganic Chemistry), both biennially meetings, are the classical conferences to obtain top-level information int he field of biological inorganic chemistry.
The first Conference was held in Newcastle in 1992, while the venue of the previous Conferences are Wroclaw 2006, Thessaloniki 2008, Barcelona 2010, Granada 2012, Zurich 2014. We line up into this illustrious series. Budapest organises the EUROBIC13 in 2016.
The scientific program will include invited plenary (8), keynote and session lectures (25-30) and contributed papers (40) and posters.
The following topics will be covered: Biocoordination chemistry: complexes of peptides, nucleotides and relatides ligands, Bioinorganic Chemistry and Nanotechnology; Biomineralization; Metals in medicine; Metal in the Environment; Metabolism of Metal ions; Metal ion sensing in Biology, Metalloproteins; Metals in the Brain; Metal ion interactions with nucleic acids; Spectroscopy and diffraction, Other topics.
We look forward to meeting you in Budapest in 2016.

http://eurobic13.mke.org.hu/external link

8th International Conference on Protein Kinase CK2
2016-09-06 to 2016-09-09
Homburg, Germany
Protein kinase CK2 is a serine/threonine kinase which is highly conserved in evolution. Knock-out experiments have shown that this enzyme is absolutely necessary for cell viability. The enzyme is highly expressed in rapidly proliferating cells which goes along with an elevated enzyme activity. Protein kinase CK2 is involved in a broad range of signaling pathways regulating proliferation, differentiation, apoptosis or senescence. Recent advances towards the characterization of the three dimensional structure of protein kinase CK2 and its subunits will undoubtedly yield important new insights into its regulation and functions of CK2. Moreover, with two inhibitors of the enzyme in clinical trials phase II at current, human protein kinase CK2 appears as an emerging target for cancer diseases.

http://www.uniklinikum-saarland.de/einrichtungen/fachrichtungen/biochemie/ag_prof_dr_mathias_montenarh/ck2/external link

Modern Drug Discovery & Development Summit (M3D)
2016-09-12 to 2016-09-15
Boston, MA

The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research and current developments in the field. The Summit will feature six conferences that will cover the latest hot topics in drug discovery:
11th Drug Design & Medicinal Chemistry
3rd Cell & Gene Therapy
Drug Delivery & Controlled Releases
7th Non-Coding RNA & RNAi Therapeutics
4th GPCR in Drug Discovery
Cell Culture & Cell Line Development

https://www.gtcbio.com/conferences/modern-drug-discovery-development-summit-m3d-overview?alias=modern-drug-discovery-development-summit-m3dexternal link

Modern Drug Discovery & Development Summit (M3D)
2016-09-13 to 2016-09-16
Boston, MA

We invite you to attend the Modern Drug Discovery & Development Summit (M3D), which will take place September 13-16, 2016 in Boston, MA. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research and current developments in the field.

For more informations, please visit the website.

https://www.gtcbio.com/conferences/modern-drug-discovery-development-summit-m3d-overviewexternal link

4th Conference on Innovation in Drug Delivery: Site-Specific Drug Delivery
2016-09-25 to 2016-09-28
Antibes-Juan-les-Pins (close to Nice), France
The fourth edition of the Conference on Innovation in Drug Delivery will be organized jointly by ADRITELF (Associazione Docenti Ricercatori Italiani di Tecnologia e Legislazione Farmaceutische), Italy, and APGI (International Society of Drug Delivery Sciences and Technology), France, in Antibes-Juan-les-Pins (France) from 25 to 28 September, 2016. The symposium topic will be “Site-Specific Drug Delivery”. It will consist in plenary and invited lectures as well as short oral presentations. The conference will also host an industrial exhibition as well as technical presentations, offered to the sponsors who would like to introduce their technology/methodology by an oral presentation.

http://idd2016.sciencesconf.org/external link